Sex Steroid Hormone Pathway Genes and Health-Related Measures in Women of 4 Races/Ethnicities: The Study of Women's Health Across the Nation (SWAN)

American Journal of Medicine

Volumn 119, Issue 9 SUPPL. 1, 2006, Pages

  Sowers, MaryFran R ^a   Wilson, Angela L ^a   Karvonen Gutierrez, Carrie A ^a   Kardia, Sharon R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Genetics; Polymorphisms; Repository; Sex hormones

Indexed keywords

APOLIPOPROTEIN A1; CYTOCHROME P450 1A1; ESTRADIOL; ESTROGEN RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; SEX HORMONE;

ADULT; AFRICAN AMERICAN; AGING; ARTICLE; BONE DENSITY; CAUCASIAN; CELL LINE; CHINESE; CLIMACTERIUM; COGNITION; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; ETHNOLOGY; FEMALE; GENE; GENE FREQUENCY; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEALTH; HEALTH STATUS; HUMAN; INSULIN SENSITIVITY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; METABOLIC SYNDROME X; OVARY; PRIORITY JOURNAL; RACE; RISK; VASOMOTOR DISORDER;

ADULT; CONTINENTAL POPULATION GROUPS; FEMALE; GENOTYPE; GONADAL STEROID HORMONES; HEALTH SURVEYS; HUMANS; MENOPAUSE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33747872891     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.07.012     Document Type: Article

References (27)

1. Kobayashi S., Inoue S., Hosoi T., Ouchi Y., Shiraki M., and Orimo H. Association of bone mineral density with polymorphisms of the estrogen receptor gene. J Bone Miner Res 11 (1996) 306-311
2. Willing M., Sowers M., Aron D., et al. Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 13 (1998) 695-705
3. Aktas D., Guney I., Alikasifoglu M., Yuce K., Tuncbilek E., and Ayhan A. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm. Gynecol Oncol 86 (2002) 124-128
4. Bailey L.R., Roodi N., Dupont W.D., and Parl F.F. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 58 (1998) 5038-5041
5. Simpson E.R., Zhao Y., Agarwal V.R., et al. Aromatase expression in health and disease. Recent Prog Horm Res 52 (1997) 185-213
6. Hall J.M., Lee M.K., Newman B., et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250 (1990) 1684-1689
7. Almeida S., Franken N., Zandona M.R., Osorio-Wender M.C., and Hutz M.H. Estrogen receptor 2 and progesterone receptor gene polymorphisms and lipid levels in women with different hormonal status. Pharmacogenomics J 5 (2005) 30-34
8. Baghaei F., Rosmond R., Westberg L., et al. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obes Res 11 (2003) 578-585
9. Iivonen S., Corder E., Lehtovitra M., et al. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology 62 (2004) 1170-1176
10. Dalla C., Antoniou K., Papadopoulou-Daifoti Z., Balthazart J., and Bakker J. Oestrogen-deficient female aromatase knockout (ArKO) mice exhibit depressive-like symptomatology. Eur J Neurosci 20 (2004) 217-228
11. Tworoger S.S., Chubak J., Aiello E.J., et al. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 13 (2004) 94-101
12. Sowers M.F., Crawford S., Sternfeld B., et al. Design, survey sampling and recruitment methods of SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo R.A., Kelsey J., and Marcus R. (Eds). Menopause: Biology and Pathobiology (2000), Academic Press, San Diego, CA 175-188
13. Kardia S.R., Chu J., and Sowers M.F. Characterizing variation in sex steroid hormone pathway genes in women of 4 races/ethnicities: the Study of Women's Health Across the Nation (SWAN). Am J Med 119 suppl 9A (2006) S3-S15
14. Sowers M.F., Jannausch M.L., McConnell D.S., Kardia S.R., and Randolph Jr. J.F. Endogenous estradiol and its association with estrogen receptor gene polymorphisms. Am J Med 119 suppl 9A (2006) 16-22
15. Sowers M.F., Wilson A.L., Kardia S.R., Chu J., and Ferrell R. Aromatase gene (CYP 19) polymorphisms and endogenous androgen concentrations in a multiethnic/multiracial, multisite study of women at midlife. Am J Med 119 suppl 9A (2006) S23-S30
16. Sowers M.F., Jannausch M.L., McConnell D.S., Kardia S.R., and Randolph Jr. J.F. Menstrual cycle markers of ovarian aging and sex steroid hormone genotypes. Am J Med 119 suppl 9A (2006) S31-S43
17. Sowers M.F., Wilson A.L., Kardia S.R., Chu J., and McConnell D.S. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal. Am J Med 119 suppl 9A (2006) S44-S51
18. Crandall C.J., Crawford S.L., and Gold E.B. Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. Am J Med 119 suppl 9A (2006) S52-S60
19. Sowers M.F., Symons J.P., Jannausch M.L., Chu J., and Kardia S.R. Sex steroid hormone polymorphisms, high-density lipoprotein cholesterol, and apolipoprotein A-1 from the Study of Women's Health Across the Nation (SWAN). Am J Med 119 suppl 9A (2006) S61-S68
20. Lo J.C., Zhao X., Scuteri A., Brockwell S., and Sowers M.F. The association of genetic polymorphisms in sex hormone biosynthesis and action with insulin sensitivity and diabetes mellitus in women at midlife. Am J Med 119 suppl 9A (2006) S69-S78
21. Greendale G.A., Chu J., Ferrell R., Randolph Jr. J.F., Johnston J.M., and Sowers M.F. The association of bone mineral density with estrogen receptor gene polymorphisms. Am J Med 119 suppl 9A (2006) S79-S86
22. Kravitz H.M., Janssen I., Lotrich F.E., Kado D.M., and Bromberger J.T. Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife. Am J Med 119 suppl 9A (2006) S87-S93
23. Kravitz H.M., Meyer P.M., Seeman T.E., Greendale G.A., and Sowers M.F. Cognitive functioning and sex steroid hormone gene polymorphisms in women at midlife. Am J Med 119 suppl 9A (2006) S94-S102
24. Gold B., Kalush F., Bergeron J., et al. Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 64 (2004) 8891-8900
25. Castagnoli A., Maestri I., Bernardi F., and Del Senno L. PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res 15 (1987) 866
26. Haiman C.A., Stram D.O., Pike M.C., et al. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet 12 (2003) 2679-2692
27. Zhang J., Rowe W.L., Clark A.G., and Buetow K.H. Genomewide distribution of high-frequency, completely mismatching SNP haplotype pairs observed to be common across human populations. Am J Hum Genet 73 (2003) 1073-1081